Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study (Q43916590)
scientific article published in February 1990
Language:
Current Data About Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study
(P31) (Q13442814)
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P304) 121-123
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P478) 8
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P577) Thursday, February 1, 1990
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P921) (Q42824440)

(P1433) (Q2312231)
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P1476) "Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study" (language: en)
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P2093) N A Iscoe
(P1545) 1
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

E A Eisenhauer
(P1545) 2
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

A J Bodurtha
(P1545) 3
(P248)
(P698) 2140563
(P813) Tuesday, November 28, 2017

(P2860) (Q33444724)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/2140563
(P813) Saturday, December 12, 2020
(P887)

(Q59647402)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/2140563
(P813) Saturday, December 12, 2020
(P887)

(Q47936317)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/2140563
(P813) Saturday, December 12, 2020
(P887)

(Q54474397)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/2140563
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article published in February 1990

External Links
(P356) 10.1007/BF00216937
(P698) 2140563
(P6179) 1038479385